SynergyMed
Medical Devices for Human and Veterinary Cancer Treatment
Company Overview
Snapshot
Founded in January 2018 by Anan Copty, SynergyMed operates with 11–50 employees. The company is currently in the Pre-Funding stage, focusing on the development of medical devices for cancer treatment.
Business overview
SynergyMed is an early-stage startup developing non-invasive medical devices for cancer treatment, applicable in both human and veterinary medicine. The company's core technology aims to replace surgical tumor resection with a system designed for rapid and effective ablation and destruction of tumors, while preserving healthy surrounding tissue. SynergyMed operates within the Health Tech & Life Sciences sector, specifically focusing on Medical Devices and Medical Treatment & Therapeutics, serving healthcare providers and pet owners across Europe, Asia, and North America.
Log in to access full profile ›Company Intelligence Q&A
- What is SynergyMed's primary focus?
- SynergyMed is focused on developing medical devices for non-invasive cancer treatment in both human and veterinary applications.
- When was SynergyMed founded?
- SynergyMed was founded in January 2018.
- Who founded SynergyMed?
- SynergyMed was founded by Anan Copty.
- What markets does SynergyMed target?
- SynergyMed targets markets in Europe, Asia, and North America.
- What is SynergyMed's current product development stage?
- SynergyMed's products are currently in the R&D stage, with the company actively developing its non-invasive solution to replace surgical tumor resection.